ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Geriatric Medicine

Top Geriatric Medicine Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GOPAL NAIR MD

Geriatric Medicine

20,207

$950K

321
262 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

33%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $61

WIT JAMRY MD

Geriatric Medicine

30,529

$2.43M

482
333 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 24%

$79
Average prescription price

Avg: $61

IQBAL AMIN M.D.

Geriatric Medicine

51,332

$2.79M

940
783 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

28%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

DEBRA BUCKLER DO

Geriatric Medicine

5,580

$270K

274
240 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

24%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $61

MOHAMMED MOJID M.D.

Geriatric Medicine

17,755

$1.1M

518
342 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $61

ROSHAN SABAR M.D.

Geriatric Medicine

18,627

$919K

374
342 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

JULIE GAMMACK MD

Geriatric Medicine

1,783

$115K

108
94 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $61

POONAM JAIN M.D.

Geriatric Medicine

10,527

$584K

237
227 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $61

KRISTI SHAUMEYER MD

Geriatric Medicine

9,404

$511K

331
262 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

25%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

TONY TANG M. D.

Geriatric Medicine

12,107

$542K

281
238 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

UCHENNA OGBUOKIRI MD

Geriatric Medicine

1,874

$83.9K

117
53 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

KEVIN FARRELL D.O.

Geriatric Medicine

17,039

$925K

395
326 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

MIRIAM RODIN MD

Geriatric Medicine

2,593

$128K

173
144 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

DAVID THOMAS MD

Geriatric Medicine

4,181

$212K

118
105 are 65+

25%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $61

DEATRICE KELLOGG MD

Geriatric Medicine

27,690

$1.7M

732
639 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $61

RIFFAT IMDAD M.D.

Geriatric Medicine

14,248

$771K

356
341 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

PAMELA MABEN MD

Geriatric Medicine

22,490

$1M

856
727 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

CHANTRI TRINH MD

Geriatric Medicine

11,605

$510K

339
282 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $61

DULCE CRUZ OLIVER MD

Geriatric Medicine

3,358

$195K

136
121 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

ERIC BARNES D.O.

Geriatric Medicine

68,611

$5.98M

1248
627 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$87
Average prescription price

Avg: $61

JOHN MORLEY MD

Geriatric Medicine

12,908

$778K

396
339 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $61

MARJON GILLBANKS M.D.

Geriatric Medicine

6,945

$363K

359
330 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $61

RAJAMANICKAM PURUSHOTHAMAN MD

Geriatric Medicine

14,089

$813K

455
401 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

SHELLEY ALEXANDER D.O.

Geriatric Medicine

5,381

$399K

161
56 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $61

RAFI KEVORKIAN MD

Geriatric Medicine

15,047

$1.05M

402
242 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank